Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Receivables (2016 - 2017)

Tenax Therapeutics' Receivables history spans 7 years, with the latest figure at $24649.0 for Q3 2017.

  • For Q3 2017, Receivables fell 66.05% year-over-year to $24649.0; the TTM value through Sep 2017 reached $24649.0, down 66.05%, while the annual FY2016 figure was $72599.0, N/A changed from the prior year.
  • Receivables for Q3 2017 was $24649.0 at Tenax Therapeutics, roughly flat from $24649.0 in the prior quarter.
  • Across five years, Receivables topped out at $166290.0 in Q1 2014 and bottomed at $24648.0 in Q2 2016.
  • The 5-year median for Receivables is $66108.0 (2014), against an average of $69702.8.
  • The largest annual shift saw Receivables tumbled 70.65% in 2014 before it surged 137.28% in 2015.
  • A 5-year view of Receivables shows it stood at $123873.0 in 2013, then plummeted by 70.65% to $36358.0 in 2014, then skyrocketed by 36.0% to $49448.0 in 2015, then surged by 46.82% to $72599.0 in 2016, then crashed by 66.05% to $24649.0 in 2017.
  • Per Business Quant, the three most recent readings for TENX's Receivables are $24649.0 (Q3 2017), $24649.0 (Q2 2017), and $24649.0 (Q1 2017).